NEW YORK, April 29-Rosetta, a Merck subsidiary, said today that it had licensed its Resolver gene expression analysis system to Japan's National Institute of Radiological Sciences.
The company did not reveal financial specifics.
Resolver is a bioinformatics system for use with DNA microarrays. It is marketed by Agilent Technologies
NIRS will use the Rosetta software for research into radiation therapy of malignancies and radiation-based disease diagnostics.
This is Rosetta Biosoftware's first license in Asia Pacific.